A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic Characteristics, and Immunogenicity of Plonmarlimab in Subjects With Rheumatic and Immunological Disease-associated Haemophagocytic Lymphohistiocytosis (HLH) (Also Known as Macrophage Activation Syndrome (MAS))
PHASE2
This study adopts an open-label, single-arm, multicenter design to evaluate...
Status
Completed
Location
Beijing Friendship Hospital, Capital Medical University
A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])
PHASE3
A study designed to evaluate the efficacy, safety, immunogenicity, PK, and ...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University